A.R.T. Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,502
| Closed | -$432K | – | 548 |
|
|
2019
Q4 | $432K | Buy |
+1,502
| New | +$432K | 0.02% | 906 |
|
|
2019
Q3 | – | Sell |
-6,862
| Closed | -$617K | – | 1578 |
|
|
2019
Q2 | $617K | Buy |
6,862
+5,901
| +614% | +$531K | 0.03% | 661 |
|
|
2019
Q1 | $84K | Sell |
961
-1,960
| -67% | -$171K | 0.01% | 1187 |
|
|
2018
Q4 | $411K | Buy |
2,921
+596
| +26% | +$83.9K | 0.03% | 805 |
|
|
2018
Q3 | $593K | Sell |
2,325
-4,816
| -67% | -$1.23M | 0.03% | 779 |
|
|
2018
Q2 | $1.82M | Buy |
7,141
+6,153
| +623% | +$1.57M | 0.07% | 395 |
|
|
2018
Q1 | $198K | Sell |
988
-1,206
| -55% | -$242K | 0.01% | 1268 |
|
|
2017
Q4 | $315K | Buy |
2,194
+424
| +24% | +$60.9K | 0.01% | 1043 |
|
|
2017
Q3 | $291K | Buy |
+1,770
| New | +$291K | 0.01% | 1023 |
|
|
2016
Q2 | – | Sell |
-4,478
| Closed | -$599K | – | 1497 |
|
|
2016
Q1 | $599K | Sell |
4,478
-652
| -13% | -$87.2K | 0.03% | 786 |
|
|
2015
Q4 | $1.02M | Sell |
5,130
-3,944
| -43% | -$783K | 0.05% | 549 |
|
|
2015
Q3 | $1.43M | Buy |
+9,074
| New | +$1.43M | 0.05% | 504 |
|
|
2015
Q2 | – | Sell |
-1,097
| Closed | -$503K | – | 1588 |
|
|
2015
Q1 | $503K | Buy |
+1,097
| New | +$503K | 0.02% | 914 |
|
|
2014
Q2 | – | Sell |
-1,018
| Closed | -$471K | – | 1424 |
|
|
2014
Q1 | $471K | Buy |
+1,018
| New | +$471K | 0.03% | 774 |
|